Laryngeal Cancer
📧 Sign up to get email alerts when something new happens for Laryngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer [Phase 2]
A Phase 2 clinical trial comparing vocal-cord-sparing radiotherapy to complete laryngeal radiotherapy for early glottic cancer is currently …
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: The Relationship Between The Differential Expression Of FosB Protein In Laryngeal Cancer Tissues And Clinical Prognosis
This clinical trial evaluates the relationship between FosB protein expression in laryngeal cancer tissues and clinical prognosis; the study…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating celecoxib added to surgery and radiation for advanced head and neck cancer; the study was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: SpeakFree Heat and Moisture Exchanger (HME) [NA]
Clinical trial evaluating SpeakFree Heat and Moisture Exchanger (HME) in patients with laryngeal cancer and after laryngectomy has completed…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Oncologic and Functional Outcome and Quality of Life in Patients Treated for Laryngeal Cancer
A clinical trial update reporting on oncologic and functional outcomes as well as quality of life in patients treated for laryngeal cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 with radiation therapy to pembrolizumab for recurrent head and neck squamous cell carcinomas, ai…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Validation and Cross-cultural Adaptation of Croatian SECEL Questionnaire
The trial update reports completion of a Croatian validation and cross-cultural adaptation of the SECEL questionnaire for laryngeal cancer p…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck [Phase 1]
Phase Ib trial of buparlisib (BKM120) with cisplatin and radiotherapy in high-risk locally advanced squamous cell carcinoma of the head and …
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Effect of Zinc and Probiotics Supplementation on Laryngeal Cancer Patients Undergoing Laryngectomy Surgery to Improve Prognosis and Better Wound Healing [NA]
A clinical trial investigating whether zinc and probiotic supplementation improves prognosis and wound healing in laryngeal cancer patients …
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] [Phase 2]
Phase 2 European Larynx Organ Preservation Study (ELOS) evaluates pembrolizumab (MK-3475) for organ-preserving treatment in squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer [Phase 1]
Phase 1 trial evaluating a WEE1 inhibitor in combination with cisplatin and radiotherapy for head and neck cancers has completed.
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating tislelizumab with induction chemotherapy for larynx preservation in resectable advanced laryngeal/hypopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin [Phase 2]
Phase 2 trial evaluating sodium thiosulfate to prevent cisplatin-induced ototoxicity in patients with head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer [NA]
A completed clinical trial update describes a new delineation approach for defining target volumes in IMRT for head and neck cancer, focusin…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating induction total parenteral nutrition followed by nivolumab and radiation for locoregionally advanced laryngeal and …
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer [Phase 2]
Phase 2 clinical trial investigating chemotherapy plus the Bcl-xL inhibitor AT-101 for organ preservation in adults with advanced laryngeal …
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating preoperative and adjuvant therapy with carboplatin, nab-paclitaxel, and durvalumab for head and neck squamous cell …
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating induction chemotherapy and toripalimab followed by radiotherapy for unresectable laryngeal or hypopharynge…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating induction chemotherapy with toripalimab for larynx preservation in resectable laryngeal/hypopharyngeal car…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Pembrolizumab in Combination With CRT for LA-SCCHN [Phase 1]
Phase 1 study evaluating pembrolizumab in combination with chemoradiotherapy for locally advanced head and neck squamous cell carcinoma has …
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma [Phase 2]
Phase 2 clinical trial evaluating phonosurgical augmentation after laser resection for early glottic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. [Phase 1, Phase 2]
Phase 1b/Phase 2 clinical trial evaluating food-based modulation of biomarkers in tissues from individuals at high risk for oral cancer has …
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer [EARLY_Phase 1]
A completed early-phase trial tested metformin hydrochloride for effects on cytokines and exosomes in patients with head and neck cancers, i…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer [Phase 1, Phase 2]
A clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for recurrent laryngeal cancer has completed Phase 1 an…
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer [Phase 2]
Phase 2 trial update evaluating TPF plus radiotherapy and cetuximab to avoid total laryngectomy in larynx cancer.